Increased Erythroid Cell Production [PE] - N0000009319

Pharmacologic Class Information

Pharmacologic Code N0000009319
Pharmacologic Name Increased Erythroid Cell Production
Pharmacologic Uses
  • erythropoiesis-stimulating agent (ESA)
Pharmacologic Concept Physiologic Effects - [PE]
Pharmacologic Concept Description This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Increased Erythroid Cell Production

The following table contains 50 products whose active ingredient are classified under the same pharmacologic class Increased Erythroid Cell Production [PE].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-1305Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
0069-1306Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
0069-1307Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
0069-1308Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
0069-1309Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
0069-1311Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
0069-1318Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
55513-002Aranesp Non-Proprietary Name: Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-003Aranesp Non-Proprietary Name: Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-004Aranesp Non-Proprietary Name: Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-005Aranesp Non-Proprietary Name: Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-006Aranesp Non-Proprietary Name: Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-021Aranesp Non-Proprietary Name: Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-023Aranesp Non-Proprietary Name: Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-025Aranesp Non-Proprietary Name: Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-027Aranesp Non-Proprietary Name: Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-028Aranesp Non-Proprietary Name: Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-032Aranesp Non-Proprietary Name: Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-057Aranesp Non-Proprietary Name: Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-098Aranesp Non-Proprietary Name: Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-110Aranesp Non-Proprietary Name: Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-111Aranesp Non-Proprietary Name: Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-126Epogen Non-Proprietary Name: Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-144Epogen Non-Proprietary Name: Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-148Epogen Non-Proprietary Name: Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-267Epogen Non-Proprietary Name: Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-283Epogen Non-Proprietary Name: Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-478Epogen Non-Proprietary Name: Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncACTIVE
59353-002Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousVifor (international) Inc.ACTIVE
59353-003Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousVifor (international) Inc.ACTIVE
59353-004Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousVifor (international) Inc.ACTIVE
59353-010Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousVifor (international) Inc.ACTIVE
59353-120Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousVifor (international) Inc.ACTIVE
59353-220Retacrit Non-Proprietary Name: Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousVifor (international) Inc.ACTIVE
59353-400Mircera Non-Proprietary Name: Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.ACTIVE
59353-401Mircera Non-Proprietary Name: Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.ACTIVE
59353-402Mircera Non-Proprietary Name: Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.ACTIVE
59353-403Mircera Non-Proprietary Name: Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.ACTIVE
59353-404Mircera Non-Proprietary Name: Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.ACTIVE
59353-405Mircera Non-Proprietary Name: Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.ACTIVE
59353-406Mircera Non-Proprietary Name: Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.ACTIVE
59353-407Mircera Non-Proprietary Name: Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.ACTIVE
59353-408Mircera Non-Proprietary Name: Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.ACTIVE
59676-302Procrit Non-Proprietary Name: ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpACTIVE
59676-303Procrit Non-Proprietary Name: ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpACTIVE
59676-304Procrit Non-Proprietary Name: ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpACTIVE
59676-310Procrit Non-Proprietary Name: ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpACTIVE
59676-312Procrit Non-Proprietary Name: ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpACTIVE
59676-320Procrit Non-Proprietary Name: ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpACTIVE
59676-340Procrit Non-Proprietary Name: ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpACTIVE